Condition 1: Hyperphosphatemia. Condition 2: Uremia. Chronic kidney disease, stage 5 Chronic kidney disease, stage 5
Conditions
Interventions
Intervention 1: Intervention group: Intervention group: They will perform an exercise program including active range of motion exercises for 2 weeks and then pedaling a stationary bike or a mini bike
Sponsors
Esfahan University of Medical Sciences
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: All dialysis patients who are over 18 years old. All dialysis patients who have a fixed number of sessions per week and undergo hemodialysis 3 times a week and each session lasts for 4 hours. All dialysis patients who have undergone hemodialysis for more than 3 months. All dialysis patients who use a permanent vascular access. All dialysis patients who are able to perform active range of motion exercises and pedal independently. All dialysis patients who have the ability to learn exercises and do not have mental disabilities. All dialysis patients who had stable hemodynamics during hemodialysis sessions in the last 1 month.
Exclusion criteria
Exclusion criteria: pregnancy. Patients with symptomatic and severe aortic stenosis Patients who have a history of lung disease that requires oxygen therapy Patients who do not have a history of stroke or transient ischemic attacks in the last 3-6 months Patients who have a history of heart attack and unstable angina in the past 3-6 months. Patients with a history of ischemic heart disease Patients who have any disorders in the musculoskeletal system (orthopedic problems, lower limb amputations, etc.) that prevent them from performing the desired sports activities Patients with uncontrolled blood pressure. Patients with uncontrolled diabetes. Patients who have a history of moderate to severe heart failure (class =II according to New York Heart Association criteria). Patients with a history of angina pectoris grade 2-4 according to the criteria of the Canadian Heart and Vascular Association
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Blood phosphorus level. Timepoint: At the beginning of the study (before the start of the intervention) and 1 and 2 months after the start of the intervention. Method of measurement: Sending the blood sample to the laboratory.;Blood urea level. Timepoint: At the beginning of the study (before the start of the intervention) and 1 and 2 months after the start of the intervention. Method of measurement: Sending the blood sample to the laboratory. | — |
Secondary
| Measure | Time frame |
|---|---|
| Quality of life. Timepoint: mortality. Method of measurement: hospitalization. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactElham Hasani
Esfahan University of Medical Sciences
Outcome results
None listed